89
Participants
Start Date
September 26, 2011
Primary Completion Date
August 10, 2017
Study Completion Date
August 10, 2017
Percutaneous transluminal angioplasty of femoropopliteal artery lesions with primary long
Patients will be randomized in a two-by-two factorial manner according to the use of IVUS guidance (IVUS guidance vs. no IVUS guidance) for the PCI and the duration of dual anti-platelet therapy (100 mg/day aspirin and 75mg/day clopidogrel for 6 months vs. 12 months) after PCI. Each randomization of the enrolled subjects will be done 1:1.
short stenting for the primary outcome and use of cilostazol for 12 months for secondary outcome.
Patients will be randomized in a two-by-two factorial manner according to the use of IVUS guidance (IVUS guidance vs. no IVUS guidance) for the PCI and the duration of dual anti-platelet therapy (100 mg/day aspirin and 75mg/day clopidogrel for 6 months vs. 12 months) after PCI. Each randomization of the enrolled subjects will be done 1:1.
Severance Hospital, Seoul
Yonsei University
OTHER